Highlander Capital Management »

Atai Life Sciences Nv shares owned by Highlander Capital Management

Quarter-by-quarter ownership of Atai Life Sciences Nv (ATAI) shares owned by Highlander Capital Management from 13F filings

Historical chart of Highlander Capital Management investment in Atai Life Sciences Nv

Tip: Access up to 7 years of quarterly data

All positions including Atai Life Sciences Nv held by Highlander Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atai Life Sciences Nv by Highlander Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $211 150 1.41
2023-09-30 $0 150 0.00

More positions owned by Highlander Capital Management

Unitedhealth Group Equities (UNH)
Apple Equities (AAPL)
Microsoft Corp Equities (MSFT)
Berkshire Hathaway Equities (BRK.B)
Stryker Corp Common Equities (SYK)
Amgen Equities (AMGN)
Home Depot Equities (HD)
Cnx Res Corp Equities (CNX)
Alphabet Inc Cap Stk Cl C Equities (GOOG)
Parker-hannifin Corp Equities (PH)
Costco Wholesale Corp Equities (COST)
Jpmorgan Chase & Co Equities (JPM)
Ingredion Equities (INGR)
Bank New York Mellon Corp Equities (BK)
Cisco Sys Equities (CSCO)

View all positions for Highlander Capital Management

Top funds holding Atai Life Sciences Nv

Marshall Wace
Millennium Management
Bank of America Corporation
Citadel Advisors
Two Sigma Investments
Vanguard Group
Franklin Resources
Jpmorgan Chase & Co
Tejara Capital
Barclays
Jane Street
Hrt Financial
Goldman Sachs Group
D. E. Shaw & Co
HPM Partners

View all funds holding Atai Life Sciences Nv